We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.83%
AUM
$43.9B
AUM Growth
+$1.29B
Cap. Flow
+$573M
Cap. Flow %
1.31%
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480

Sector Composition

Rank Sector Weight
1 Technology 15.57%
2 Healthcare 13.05%
3 Financials 12.83%
4 Industrials 10.11%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRFS
651
DELISTED
BRF SA
BRFS
$11M 0.03%
2,698,868
+1,533,509
+132% +$5.39M
CSGP icon
652
CoStar Group
CSGP
$12.2B
$10.9M 0.02%
+147,295
New +$12.5M
SAM icon
653
Boston Beer
SAM
$1.92B
$10.9M 0.02%
35,679
-3,327
-9% -$953K
VC icon
654
Visteon
VC
$2.79B
$10.8M 0.02%
101,302
+47,791
+89% +$5.28M
SCHG icon
655
Schwab US Large-Cap Growth ETF
SCHG
$62.2B
$10.7M 0.02%
426,400
-113,600
-21% -$2.68M
NMFC icon
656
New Mountain Finance
NMFC
$694M
$10.7M 0.02%
877,412
-309,839
-26% -$3.88M
KGS icon
657
Kodiak Gas Services
KGS
$5.84B
$10.7M 0.02%
393,784
-84,467
-18% -$2.29M
GPOR icon
658
Gulfport Energy Corp
GPOR
$2.81B
$10.7M 0.02%
70,947
-35,962
-34% -$5.64M
RF icon
659
Regions Financial
RF
$27.2B
$10.7M 0.02%
533,831
+455,631
+583% +$8.84M
RXRX icon
660
Recursion Pharmaceuticals
RXRX
$1.68B
$10.7M 0.02%
1,426,242
+529,762
+59% +$4.62M
DV icon
661
DoubleVerify
DV
$1.84B
$10.6M 0.02%
+543,488
New +$13.1M
AMBA icon
662
Ambarella
AMBA
$3.59B
$10.6M 0.02%
196,080
-39,845
-17% -$1.98M
TRUP icon
663
Trupanion
TRUP
$1.06B
$10.6M 0.02%
359,024
+80,109
+29% +$2.12M
NOV icon
664
NOV
NOV
$6.95B
$10.5M 0.02%
552,329
-1,441,227
-72% -$27M
BYD icon
665
Boyd Gaming
BYD
$6.13B
$10.5M 0.02%
+189,817
New +$10.8M
ZETA icon
666
Zeta Global
ZETA
$6.75B
$10.4M 0.02%
591,404
+525,990
+804% +$7.72M
KYMR icon
667
Kymera Therapeutics
KYMR
$8.68B
$10.4M 0.02%
348,918
+221,172
+173% +$7.66M
VECO icon
668
Veeco
VECO
$3.23B
$10.4M 0.02%
222,609
-74,536
-25% -$2.95M
BCRX icon
669
BioCryst Pharmaceuticals
BCRX
$2.31B
$10.3M 0.02%
1,674,391
+99,750
+6% +$550K
NVMI
670
Nova
NVMI
$12.8B
$10.3M 0.02%
44,006
+38,770
+740% +$7.68M
MRCY icon
671
Mercury Systems
MRCY
$6.45B
$10.3M 0.02%
381,684
+29,763
+8% +$868K
SWKS icon
672
Skyworks Solutions
SWKS
$10.1B
$10.3M 0.02%
96,454
+78,623
+441% +$7.75M
CSW
673
CSW Industrials
CSW
$5.64B
$10.3M 0.02%
38,688
+29,185
+307% +$7.24M
BTE icon
674
Baytex Energy
BTE
$2.9B
$10.2M 0.02%
2,919,963
+1,158,322
+66% +$4.14M
SLGN icon
675
Silgan Holdings
SLGN
$4.51B
$10.1M 0.02%
239,703
+118,667
+98% +$5.51M

Similar funds

Two Sigma Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Two Sigma Investments held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Two Sigma Investments's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Two Sigma Investments's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
  • Two Sigma Investments added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
  • Two Sigma Investments's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
  • Two Sigma Investments fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
  • Two Sigma Investments's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
  • Two Sigma Investments opened 479 new positions and closed 480 in Q2 2024.
  • Two Sigma Investments's portfolio value rose 3% quarter-over-quarter to $43.9B.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.